A Clinical Study of MK-1045 in People With Lupus or Rheumatoid Arthritis (MK-1045-004)

Clinical trial NCT07363590 · RECRUITING

Trial details

NCT number: NCT07363590
Sponsor: Merck Sharp & Dohme LLC
Status: RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Systemic Lupus Erythematosus Rheumatoid Arthritis

Start date: 2026-02-19
Primary completion: 2029-07-16
Enrollment: 21

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.